Investor Relations

Webcasts and Presentations

Neurocrine Biosciences to Present at the TD Cowen 45th Annual Health Care Conference

Feb. 25, 2025

Neurocrine Biosciences Conference Call and Webcast of Fourth Quarter and Year-End 2024 Financial Results

Feb. 6, 2025

Download

03/11/25

Neurocrine Biosciences to Present at the Stifel 2025 Virtual CNS Forum

03/05/25

Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBI-1140675, a Second-Generation VMAT2 Inhibitor, in Healthy Adults

Press Release Webcast Presentation

Filing Date	Form	Description	Filing Group	View
03/06/25	SCHEDULE 13G/A	SCHEDULE 13G/A - Description		View the html document View the rtf document View the pdf document View the xls document
02/14/25	4	Statement of changes in beneficial ownership of securities	3,4,5	View the html document View the rtf document View the pdf document View the xls document
02/14/25	4	Statement of changes in beneficial ownership of securities	3,4,5	View the html document View the rtf document View the pdf document View the xls document